Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individualsJorge F. Vázquez‐Castellanos, Andrés Moyá, Sergio Serrano‐Villar et al.|Mucosal Immunology|2014Cited by 332
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjectsSergio Serrano‐Villar, Vicente Estrada, Jorge F. Vázquez‐Castellanos et al.|Mucosal Immunology|2016Cited by 133
Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohortYolanda M. Pacheco, M. Leal, Inmaculada Jarrín et al.|Antiviral Research|2015Cited by 95
Zinc alpha‐2 glycoprotein is implicated in dyslipidaemia in <scp>HIV</scp>‐1‐infected patients treated with antiretroviral drugsVictòria Ceperuelo‐Mallafré, J‐J Sirvent, R Pastor et al.|HIV Medicine|2012Cited by 20
HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasmaJoaquim Peraire, Francesc Vidal, Miguel López-Dupla et al.|Clinical Microbiology and Infection|2015Cited by 12